AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-9371296/new-orphan-drug-named.html" title="Facts and information about New orphan drug named. (TLC G-65 for Mycobacterium avium-intracellular infection) (The Liposome Company)">New orphan drug named. (TLC G-65 for Mycobacterium avium-intracellular infection) (The Liposome Company)</a>
Close
Set up an RSS feed that alerts you when new articles from AIDS Weekly are available.
Frequently asked questions about RSS feeds
New orphan drug named. (TLC G-65 for Mycobacterium avium-intracellular infection) (The Liposome Company)
The Princeton, N.J., drug manufacturer The Liposome Company, Inc. has announced that TLC G-65, a gentamicin liposome injection for the treatment of disseminated Mycobacterium avium-intracellular (MAI) infection has been given orphan drug status by the Food and Drug Administration.
Between 30 and 50 percent of AIDS patients in the United States suffer from …
Related articles from newspapers, magazines, journals, and more
-
- Filing for offering of 3 million common shares announced for funding MAI...
-
Newspaper article from: AIDS Weekly
February 25, 1991
700+ words
-
- TLC G-65 Phase III trials started in Europe. (new drug for Mycobacterium...
-
Newspaper article from: AIDS Weekly
August 17, 1992
700+ words
-
- Consolidation of corporate research activities announced. (The Liposome Company)
-
Newspaper article from: AIDS Weekly
January 28, 1991
700+ words
-
- Liposomal drug shows activity against MAI. (Mycobacterium...
-
Newspaper article from: AIDS Weekly
July 1, 1991
700+ words
-
- Liposomal drug shows activity against MAI in AIDS patients. (VII...
-
Newspaper article from: AIDS Weekly
August 5, 1991
700+ words
